97152 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
Sub-classes:Bovine Preputial Epithelium Produces Antibodies Against Tritrichomonas foetus following Aerosol Application of Synthetic mRNA
#2POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE
#3METHODS OF IMMUNOTHERAPY
#4ANTI-MALARIA PARASITE ANTIBODY
#5ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#6CRYPTOSPORIDIOSIS VACCINE
#7COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
#8COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
#9Immunologically active fragments of toxoplasma gondii
#10ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
#11Reduction of viral disease transmission by avian antibodies
#12B-cell epitope of cysteine protease inhibitor, hybridoma cell line, monoclonal antibody and uses thereof
#13ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#14CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#15MOLECULAR DETECTION USING LIGATION AMPLIFICATION
#16METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF ANTIBODIES AGAINST INFECTIOUS DISEASES
#17Hyperimmunized egg product for treatment of necrotic enteritis in poultry
#18CD20-BINDING IMMUNOTOXINS FOR INDUCING CELLULAR INTERNALIZATION AND METHODS USING SAME
#19TREATMENT AND DETECTION OF TRYPANOSOMES
#20ANTI-T. CRUZI ANTIBODIES AND METHODS OF USE
#21Molecular detection using ligation amplification
#22NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS
#23ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#24MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS
#25CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES
#26Hyperimmunized egg product for treatment of necrotic enteritis in poultry
#27Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
#28TREATMENT AND DETECTION OF TRYPANOSOMES
#29polypeptides and methods of use
#30Antibodies to the surface of oocysts and methods of use thereof
#31Heartworm vaccine, methods and uses thereof
#32Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
#33Anti-antibodies and methods of use
#34polypeptides and methods of use
#35CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#36Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
#37CD20-binding immunotoxins for inducing cellular internalization and methods using same
#38Human antibodies to serum resistance-associated protein from trypanosoma brucei rhodesiense
#39polypeptides and methods of use
#40Hemoglobin receptor as novel vaccine for leishmaniasis
#41Anti-antibodies and methods of use
#42Canine babesiosis vaccine antigen
#43Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
#44Optimized antigens of pneumocystis and use thereof
#45polypeptides and methods of use
#46Monoclonal antibody production by EBV transformation of B cells
#47Targeted cryptosporidium biocides
#48ANTI-TRYPANOSOME THERAPEUTIC AND DIAGNOSTIC APPLICATIONS
#49BIOMARKER ANTIBODY AND DIAGNOSIS DEVICE FOR DETECTING CERTAIN AUTOIMMUNE DISEASES
#50Anti-antibodies and methods of use
#51Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof
#52Mixtures of binding proteins
#53MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS
#54System for selective cell treatment using ideotypically modulated pharmacoeffectors
#55IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS
#56Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#57Babesia Subtilisin
#58Targeted cryptosporidium biocides
#59TARGETED BIOCIDES
#60TARGETED BIOCIDES
#61Monoclonal antibody production by EBV transformation of B cells
#62Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
#63oocyst protein
#64Toxoplasma gondii Oocyst Protein
#65Anti-T. Cruzi Antibodies and Methods of Use
#66Lutzomyia longipalpis polypeptides and methods of use
#67Compositions for detecting antibodies to and methods of uses thereof
#68Immunoglobulin Directed Biocides
#69AMEBIASIS VACCINE
#71Antimicrobial Peptide Biocides
#72Innate Immune Receptor Directed Biocides
#73Coccidiosis poultry vaccine
#74Neospora caninum isolate
#75Neospora caninum isolate
#76Somatic transgene immunization and related methods
#77Method of Treating Diseases and Disorders
#78Reagent and method for detecting a sporozoite antigen
#79Immunoglobulins devoid of light chains
#80Recombinant Neospora antigens and their uses
#81Use of a novel eimeria gene and corresponding protein
#82Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#83Equine protozoal myeloencephalitis vaccine
#84Targeted biocides
#85Immunoglobulins devoid of light chains
#86Mixture of binding proteins
#87Babesia vaccines
#88Method for screening a library of VHH polypeptides
#89GLURP-MSP3 fusion protein, immunogenic compositions and malarial vaccines containing it
#90Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic
#91Leishmania antigens suitable for a diagnostic kit of Leishmania
#92Specific isotype antibodies of secretion-excretion anti-antigens of leishmania sp of promastigote or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effectors
#93Immunoglobulins devoid of light chains
#94Immunoglobulins devoid of light chains
#95Methods for detection of pathogens in red blood cells
#96Compositions against chicken coccidiosis
#97polypeptides and methods of use
#98Compositions for prevention and treatment of infections caused by coccidia in chickens
#99Trypanosome derived apoptotic factors (TAF)
#100Toxoplasma gondii apical membrane antigen-1
#101Flavor active modified thaumatin and monellin and methods for their production and use
#102Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#103AntiI-protozoal vaccine
#104GLURP-MSP3 fusion protein, immunogenic compositions and malarial vaccines containing it
#105Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
#106Use of immunoglobulins from egg yolk to treat infections caused by parasites both in animals and in humans
#107Targeted biocides
#108Recombinant neospora antigens and their uses